我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
211
30 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2008
进行中(未招募)
7
3.3%
已完成
104
49.3%
Enrolling By Invitation
1
0.5%
尚未招募
22
10.4%
招募中
29
13.7%
暂停
终止
14
6.6%
Unknown
30
14.2%
撤回
3
1.4%
暂无批准数据
- ONWARD Medical has successfully implanted its ARC-BCI® Therapy in two additional patients, bringing the total to five individuals with spinal cord injuries who can now potentially control movement through thought. - The innovative DigitalBridge™ system creates a wireless connection between brain and spinal cord, using AI to decode neural signals and translate intention into movement, bypassing damaged neural pathways. - With FDA Breakthrough Device Designation and growing clinical evidence, ONWARD's less invasive BCI approach is positioning the company as a leader in neurotechnology for restoring function after paralysis.